Mark Doerr

Mark Doerr is a principal and senior research analyst at Tech Insider covering medical technology companies with a focus on cardiovascular and related therapeutic technology. Mark leverages his prior experience as the director of marketing and business development at a medical device company, along with an extensive network of physician and industry relationships, to provide a unique perspective on the medtech sector. Prior to joining Tech Insider in 2011 he covered medical technology for four years at Craig-Hallum Capital, and has in total 20 years of financial and medtech industry experience.

Diversified Computer Systems: Hewlett-Packard Company (NYSE:HPQ), Diebold (NYSE:DBD), Cray (NASDAQ:CRAY), Silicon Graphics International (NASDAQ:SGI)

Hewlett-Packard Company (NYSE:HPQ) VP Jeff Ricci sold 3,729 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $29.97, for a total transaction of $111,758.13. Following the completion of the sale, the vice president now directly owns 967…

Read More

Investor’s Watch List: Tesla Motors Inc (NASDAQ:TSLA), BlackBerry Ltd (NASDAQ:BBRY), Apple Inc. (NASDAQ:AAPL), Nokia Corporation (ADR) (NYSE:NOK)

Tesla Motors Inc (NASDAQ:TSLA) is still waging a battle to be able to sell its cars directly to consumers in several states, including Arizona. Tesla Motors Inc (NASDAQ:TSLA) stock performance was -2.99% in last session and finished the day at $238.84. Traded volume was 7,728,100 million shares in the last session and the average volume…

Read More

Most Volatile Stocks: National Bank of Greece (NYSE:NBG), Turquoise Hill Resources (NYSE:TRQ), Himax (NASDAQ:HIMX), FuelCell Energy (NASDAQ:FCEL)

Deutsche Bank initiates coverage of National Bank of Greece (ADR) (NYSE:NBG) and of Alpha Bank in a report dated March 10, saying that the target prices also reflect its assumption that 25% of delinquent loans could become performing over time. National Bank of Greece (ADR) (NYSE:NBG) stock performance was 12.66% in last session and finished…

Read More

Pharma in Focus After Hours: Kythera (NASDAQ:KYTH), La Jolla Pharmaceutical (NASDAQ:LJPC), Medifast (NYSE:MED)

Kythera (NASDAQ:KYTH) and Bayer ADR (OTCMRKTS:BAYRY) announced that Kythera acquired all rights outside of the U.S. and Canada to ATX-101, a proprietary formulation of a purified synthetic version of deoxycholic acid currently in late-stage development for the reduction of submental fat (double chin). In 2010, KYTHERA (NASDAQ:KYTH) licensed the commercial rights to ATX-101 outside of…

Read More

Healthcare New Highs: China Cord Blood Corporation (NYSE:CO), Corcept Therapeutics (NASDAQ:CORT), Nordion (NYSE:NDZ), Vision-Sciences (NASDAQ:VSCI)

Stocks Almost Family and Chemed hold a Zacks Rank #1(Strong Buy) and China Cord Blood Corporation (NYSE:CO) holds a Zacks Rank #2 (Buy). With favorable Zacks Ranks, these stocks may be better selections at this time. China Cord Blood Corporation (NYSE:CO) stock performance was 3.26% in last session and finished the day at $4.44. Traded…

Read More
FB Nasdaq FB Facebook

Healthcare Active Stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), Merck & Co (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA), Abbott Laboratories (NYSE:ABT)

Shares of Peregrine Pharmaceuticals (NASDAQ: PPHM ) , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer, dipped as much as 11% after reporting its third-quarter earnings results. Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was -8.05% in last session and finished the day at $2.40. Traded volume was 14.14million shares in the last session…

Read More